Search Results - "Adamsson Eryd, Samuel"

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation by Savarese, Gianluigi, Kishi, Takuya, Vardeny, Orly, Adamsson Eryd, Samuel, Bodegård, Johan, Lund, Lars H., Thuresson, Marcus, Bozkurt, Biykem

“…Guidelines recommend early initiation of multiple guideline-directed medical therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart…”
Get full text

Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts by Adamsson Eryd, Samuel, Smith, J Gustav, Melander, Olle, Hedblad, Bo, Engström, Gunnar

“…OBJECTIVE—Elevated levels of blood leukocytes have been associated with acute coronary events (CEs), but data on leukocyte subclasses are limited. This study…”
Get full text

The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid‐related and phenotypic groups by Ambery, Philip, Adamsson Eryd, Samuel, Jenkins‐Jones, Sara, Heywood, Ben, Berni, Ellen, Brown, Mary N., Astbury, Carol, Hunt, Phillip, Currie, Craig J.

“…Aims Exposure to corticosteroids is known to increase the risk of developing type 2 diabetes. We estimated the risk of incident type 2 diabetes in selected…”
Get full text

Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD) by Svensson, Maria K, Tangri, Navdeep, Bodegård, Johan, Adamsson Eryd, Samuel, Thuresson, Marcus, Sofue, Tadashi

“…Background We compared kidney and cardiorenal protection in patients without type 2 diabetes across urine albumin-creatinine ratio (UACR) levels after…”
Get full text

Treatment of hypertension in old patients without previous cardiovascular disease by Bager, Johan-Emil, Hjerpe, Per, Manhem, Karin, Björck, Staffan, Franzén, Stefan, Rosengren, Annika, Adamsson Eryd, Samuel

“…OBJECTIVE:The aim of this study was to compare the risk of cardiovascular disease (CVD) – nonfatal acute myocardial infarction (AMI) or stroke – at blood…”
Get full text

Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF by Bozkurt, Biykem, Savarese, Gianluigi, Adamsson Eryd, Samuel, Bodegård, Johan, Cleland, John G F, Khordoc, Cindy, Kishi, Takuya, Thuresson, Marcus, Vardeny, Orly, Zhang, Ruiqi, Lund, Lars H

“…There are few contemporary data on outcomes, costs, and treatment following a hospitalization for heart failure (hHF) in epidemiologically representative…”
Get full text

Mortality, Health Care Burden, and Treatment of CKD: A Multinational, Observational Study (OPTIMISE-CKD) by Tangri, Navdeep, Svensson, Maria K, Bodegård, Johan, Adamsson Eryd, Samuel, Thuresson, Marcus, Gustafsson, Stefan, Sofue, Tadashi

“…Background Kidney-protective treatments (renin-angiotensin system inhibitors and sodium-glucose cotransporter-2 inhibitors [SGLT-2is]) can delay CKD…”
Get full text

Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study by Ödesjö, Helena, Björck, Staffan, Franzén, Stefan, Hjerpe, Per, Manhem, Karin, Rosengren, Annika, Thorn, Jörgen, Adamsson Eryd, Samuel

“…ObjectivesThe protective effect of lipid-lowering treatment for secondary prevention after coronary heart disease (CHD) has been well documented. Current…”
Get full text

Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study by Eryd, Samuel Adamsson, Smith, J. Gustav, Melander, Olle, Hedblad, Bo, Engström, Gunnar

“…Low-grade inflammation has been repeatedly associated with cardiovascular diseases but the relationship with incidence of atrial fibrillation (AF) remains…”
Get full text

Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium by Norby, Faye L, Eryd, Samuel Adamsson, Niemeijer, Maartje N, Rose, Lynda M, Smith, Albert V, Yin, Xiaoyan, Agarwal, Sunil K, Arking, Dan E, Chasman, Daniel L, Chen, Lin Y, Eijgelsheim, Mark, Engström, Gunnar, Franco, Oscar H, Heeringa, Jan, Hindy, George, Hofman, Albert, Lutsey, Pamela L, Magnani, Jared W, McManus, David D, Orho-Melander, Marju, Pankow, James S, Rukh, Gull, Schulz, Christina-Alexandra, Uitterlinden, André G, Albert, Christine M, Benjamin, Emelia J, Gudnason, Vilmundur, Smith, J Gustav, Stricker, Bruno H C, Alonso, Alvaro

“…Several studies have shown associations between blood lipid levels and the risk of atrial fibrillation (AF). To test the potential effect of blood lipids with…”
Get full text

Renal Protective Treatment Use for Non-Diabetic CKD in Japan, Sweden, and the United States: TH-PO1005 by Tangri, Navdeep, Svensson, Maria K., Bodegard, Johan, Eryd, Samuel Adamsson, Thuresson, Marcus, Sofue, Tadashi

Get full text

Hospital Health Care Costs Following Incident CKD in Japan, Sweden, and the United States: SA-OR36 by Tangri, Navdeep, Svensson, Maria K., Sofue, Tadashi, Bodegard, Johan, Eryd, Samuel Adamsson, Thuresson, Marcus, Gustafsson, Stefan

Get full text

Dapagliflozin in Patients with Low and High uACR: PUB322 by Tangri, Navdeep, Svensson, Maria K., Bodegard, Johan, Eryd, Samuel Adamsson, Thuresson, Marcus, Sofue, Tadashi

Get full text

MORTALITY, CLINICAL EVENTS AND HEALTHCARE COSTS AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE: INSIGHTS FROM EVOLUTION HF by Bozkurt, Biykem, Savarese, Gianluigi, Eryd, Samuel Adamsson, Bodegard, Johan, Khordoc, Cindy, Thuresson, Marcus, Vardeny, Orly, Lund, Lars, Kishi, Takuya

Get full text

Abstract 11412: Use of Guideline-Directed Medical Therapies After Hospitalization for Heart Failure: Real-World Insights From EVOLUTION HF by Bozkurt, Biykem, Savarese, Gianluigi, Adamsson Eryd, Samuel, Bodegard, Johan, Khordoc, Cindy, Thuresson, Marcus, Vardeny, Orly, Kishi, Takuya, Lund, Lars H

“…IntroductionIn the period after hospitalization for heart failure (hHF), patients are at high risk of cardiovascular death and rehospitalization. Guidelines…”
Get full text

Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study by Adamsson Eryd, Samuel, Gudbjörnsdottir, Soffia, Manhem, Karin, Rosengren, Annika, Svensson, Ann-Marie, Miftaraj, Mervete, Franzén, Stefan, Björck, Staffan

“…Objectives To compare the risk associated with systolic blood pressure that meets current recommendations (that is, below 140 mm Hg) with the risk associated…”
Get full text

Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) by Savarese, Gianluigi, Kishi, Takuya, Vardeny, Orly, Adamsson Eryd, Samuel, Bodegård, Johan, Lund, Lars H, Thuresson, Marcus, Bozkurt, Biykem

“…Guidelines recommend early initiation of multiple guideline-directed medical therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart…”
Get full text

1067-P: Short-Term Risk of Type 2 Diabetes Mellitus in Adults Treated with Corticosteroids: An Observational Study by BERNI, ELLEN, JENKINS-JONES, SARA, ASTBURY, CAROL, BROWN, MARY N., HUNT, PHILLIP R., CURRIE, CRAIG J., ERYD, SAMUEL ADAMSSON, AMBERY, PHILIP

“…Background: Exposure to corticosteroids is recognised to increase the risk of developing type 2 diabetes (T2DM). Our aim was to evaluate the short-term…”
Get full text

Red blood cell distribution width is associated with incidence of atrial fibrillation by Adamsson Eryd, S., Borné, Y., Melander, O., Persson, M., Smith, J. G., Hedblad, B., Engström, G.

“…Objectives Red blood cell distribution width (RDW), a measure of variation in erythrocyte volume, has been associated with several cardiovascular disorders,…”
Get full text

Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case–control study by Mourtzinis, Georgios, Adamsson Eryd, Samuel, Rosengren, Annika, Björck, Lena, Adiels, Martin, Johannsson, Gudmundur, Manhem, Karin

“…Abstract Background Atrial fibrillation is associated with hyperthyroidism. Patients with primary aldosteronism have an increased prevalence of atrial…”
Get full text